U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 2C4H7O2.Mn
Molecular Weight 229.1324
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MANGANESE BUTYRATE

SMILES

[Mn++].CCCC([O-])=O.CCCC([O-])=O

InChI

InChIKey=BLMXJJXSWRYMCS-UHFFFAOYSA-L
InChI=1S/2C4H8O2.Mn/c2*1-2-3-4(5)6;/h2*2-3H2,1H3,(H,5,6);/q;;+2/p-2

HIDE SMILES / InChI

Molecular Formula C4H7O2
Molecular Weight 87.0972
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Mn
Molecular Weight 54.938
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including http://jamanetwork.com/journals/jama/article-abstract/1159445 | http://pubs.acs.org/doi/abs/10.1021/cg200649n

Manganese butyrate is is a water soluble crystalline salt composed of manganese and butyrate with the formula C8H14MnO4. Manganese butyrate is especially valuable in boils, carbuncles, erysipelas, whitlows, lymphangitis and lymphadenitis. The drug is equally useful in acute gonococcal urethritis, abscess formation, epididymitis, and in gonococcal septicaemia, if prescribed in time. Manganese butyrate relieves in asthma as it changes the condensation of the protein particles, which causes the condition, into dispersion. In all septic conditions including tonsillitis, quinsy, and even rhinitis, manganese butyrate should be given a chance before an incision is made.

Originator

Sources: Voprosy Khim. Terpenov i Terpenoidov, Akad. Nauk Litovsk. S.S.R., Trudy Vsesoyuz. Soveshchaniya, Vil'nyus, Volume Date 1959, Pages 103-11, Journal, 1960

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Unknown

Approved Use

Unknown
Primary
Unknown

Approved Use

Unknown
Patents

Patents

Sample Use Guides

Two intramuscular injections of 1.0-1.5 ml a 1 per cent. solution of manganese butyrate, with three or four clear days' interval between them.
Route of Administration: Intramuscular
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:10:40 UTC 2023
Edited
by admin
on Fri Dec 15 19:10:40 UTC 2023
Record UNII
62X0EQ558R
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MANGANESE BUTYRATE
Systematic Name English
BUTANOIC ACID, MANGANESE(2+) SALT
Systematic Name English
BUTANOIC ACID, MANGANESE(2+) SALT (2:1)
Systematic Name English
MANGANESE DIBUTYRATE
Systematic Name English
BUTYRIC ACID, MANGANESE(2+) SALT
Systematic Name English
MANGANESE(II) BUTYRATE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID90210419
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
PRIMARY
PUBCHEM
160812
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
PRIMARY
CAS
6147-00-8
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
PRIMARY
ECHA (EC/EINECS)
228-154-6
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
PRIMARY
ECHA (EC/EINECS)
243-213-6
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
ALTERNATIVE
FDA UNII
62X0EQ558R
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
PRIMARY
CAS
19664-95-0
Created by admin on Fri Dec 15 19:10:40 UTC 2023 , Edited by admin on Fri Dec 15 19:10:40 UTC 2023
NON-SPECIFIC STOICHIOMETRY
Related Record Type Details
PARENT -> SALT/SOLVATE
PARENT -> SALT/SOLVATE